The total return over the past 12 months is -6.56% vs. +16.94% for the S&P 500. So far it's up -20.29% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (6.56%) | (1.05%) | (7.12%) | (6.99%) | +1.73% | (2.17%) |
| Total Return CAGR | (6.56%) | (1.05%) | (7.12%) | (6.99%) | +1.73% | (2.17%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Lifecore Biomedical, Inc. (LFCR)
| Year | Start price | End price | LFCR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $8.18 | $6.52 | (20.29%) | +14.51% | (34.80%) |
| 2025 | $7.43 | $8.18 | +10.09% | +17.72% | (7.63%) |
| 2024 | $6.19 | $7.43 | +20.03% | +24.89% | (4.86%) |
| 2023 | $6.48 | $6.19 | (4.48%) | +26.19% | (30.67%) |
| 2022 | $11.10 | $6.48 | (41.62%) | (18.17%) | (23.45%) |
| 2021 | $10.85 | $11.10 | +2.30% | +28.74% | (26.44%) |
| 2020 | $11.31 | $10.85 | (4.07%) | +18.37% | (22.44%) |
| 2019 | $11.84 | $11.31 | (4.48%) | +31.22% | (35.70%) |
| 2018 | $12.60 | $11.84 | (6.03%) | (4.56%) | (1.47%) |
| 2017 | $13.80 | $12.60 | (8.70%) | +21.70% | (30.40%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
